CALGARY,
AB, April 26, 2023 /CNW/ - Nanalysis
Scientific Corp. ("Nanalysis" or the "Company", TSXV:
NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce it has closed
the first tranche of its previously announced non-brokered private
placement on April 21, 2023 (the "Offering").The
Company has issued a total of 3,738,667 units ("Units") at
a price of $0.60 per Unit for gross
proceeds of $2,243,200. Each Unit
consisted of one common share in the capital of the Company (a
"Common Share") and one Common Share purchase warrant
(a "Warrant"). Each Warrant entitles the holder thereof to
purchase one Common Share at a price of $0.80 per Common Share (the "Warrant
Exercise Price") at any time up to 4:00 p.m. (Calgary time) on or before the date that is
one year following the closing date of the Offering.
The net proceeds of the Offering will be used by the Company for
working capital purposes. The Company expects to close on the
second tranche of the Offering on or about May 1, 2023.
Finders acting in connection with the first tranche closing
received fees in the aggregate amount of $12,600.
All securities issued in connection with the Offering will not
be able to be traded in Canada, or
through the facilities of the TSX Venture Exchange, for a period
of four months and one day from the date of closing. The
Offering is subject to final TSX Venture Exchange acceptance.
About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF,
FRA: 1N1)
Nanalysis' business is what we term "MRI and NMR for industry".
The Company develops and manufactures portable Nuclear Magnetic
Resonance (NMR) spectrometers or analyzers for laboratory and
industrial markets. The NMReady-60™ was the first full-feature
portable NMR spectrometer in a single compact enclosure requiring
no liquid helium or any other cryogens. The company has followed-up
that initial offering with new products and continues to have a
strong innovation pipeline. In 2020 Nanalysis announced the launch
of its100MHz device,the most powerful and most advanced compact NMR
device ever brought to market.
Nanalysis' devices are used in many industries (oil and gas,
chemical, mining, pharma, biotech, flavor and fragrances,
agrochemicals, law enforcement, and more) as well as numerous
government and university research labs around the world. The
Company continues to exploit new global market opportunities
independently and with partners.
In 2022 the Company acquired K'(Prime) Technologies Inc.
(KPrime), a North American sales and service company of over 40
individuals who cover scientific instrumentation for pharma, food,
chemical and oil & gas customers, as well as imaging systems
for security applications.
Additionally in 2022, the Company acquired a 43% ownership in
Quad Systems AG ("Quad Systems"), a Zurich-based Nuclear
Magnetic Resonance (NMR) company focused on high-field NMR for
pharmaceutical and other vertical markets.
Notice regarding Forward Looking Statements and Legal
Disclaimer
This news release contains certain "forward-looking
statements" within the meaning of such statements under applicable
securities law relating to the use of net proceeds of the Offering,
regulatory approval for the Offering and statements relating
to the successful closing of the second tranche of the Offering and
anticipated timing thereof and other matters ancillary or
incidental to the foregoing.
All statements included herein, other than statements of
historical fact, may be forward-looking information and such
information involves various risks and uncertainties.
Forward-looking information is often, but not always, identified by
the use of words such as "anticipates", "plan", "continue",
"expect", "project", "intend", "believe", "anticipate", "estimate",
"may", "will", "potential", "proposed", "positioned" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. These statements are only predictions.
Various assumptions were used in drawing the conclusions or making
the projections contained in the forward-looking statements
throughout this news release. Forward-looking statements are based
on the opinions and estimates of management at the date the
statements are made and are subject to a variety of risks and
uncertainties and other factors that could cause actual events or
results to differ materially from those projected in the
forward-looking statements. The Company is under no obligation, and
expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services
Provider accepts responsibility for the adequacy or accuracy of
this release.
View original
content:https://www.prnewswire.com/news-releases/nanalysis-scientific-corp-announces-closing-of-first-tranche-of-private-placement-301808678.html
SOURCE Nanalysis Scientific Corp.